Century Therapeutics, Inc. (IPSC) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -25.24M | -16.08M | -25.58M | -27.59M | -34.62M | -24.22M | -28.33M | -27.33M | -30.25M | -26.23M | -13.65M | -19.25M |
| Operating CF Margin % | - | - | - | - | -31.72% | -580.47% | -3581.8% | -3545.01% | -3537.78% | -9787.31% | -9222.3% | -19444.44% |
| Operating CF Growth % | 27.09% | 33.63% | 9.7% | -0.95% | -14.46% | 7.65% | -107.58% | -41.98% | -3.52% | -14.51% | 43.69% | 24.68% |
| Net Income | -21.64M | -19.17M | -34.43M | -32.54M | 76.56M | -36.07M | -31.23M | -31.21M | -28.06M | -39.4M | -32.72M | -33.29M |
| Depreciation & Amortization | 3M | 3.55M | 3.13M | 3.2M | 3.22M | 3.32M | 3.3M | 3.46M | 3.23M | 3.55M | 3.35M | 3.23M |
| Stock-Based Compensation | 0 | 1.3M | 892K | 2.22M | 2.43M | 2.66M | 0 | 3.5M | 3.21M | 3.56M | 3.98M | 3.29M |
| Deferred Taxes | 0 | -73K | 0 | 0 | 0 | 870K | 0 | 0 | 0 | 0 | 0 | 4.22M |
| Other Non-Cash Items | -172K | -4.84M | 5.62M | -8K | -618K | 3.17M | 2.37M | -3.8M | 427K | 8.96M | -437K | -787K |
| Working Capital Changes | -6.43M | 3.16M | -795K | -466K | -116.21M | 1.83M | -2.77M | 713K | -9.05M | -2.91M | 12.18M | 4.09M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.63M | 2.16M | -591K | -365K | 361K | 477K | -757K | -1.88M | 689K | -2.89M | 3.99M | -514K |
| Cash from Investing | -112.61M | 22.36M | 24.67M | 32.54M | 27.93M | 30.61M | 39.2M | -33.86M | 11.54M | 18.6M | 4.22M | 6.97M |
| Capital Expenditures | -584K | -317K | -195K | -317K | 0 | 0 | 804K | -265K | -539K | -980K | -3.27M | -4.5M |
| CapEx % of Revenue | - | - | - | - | - | 3.69% | 101.64% | 34.37% | 63.04% | 365.67% | 2206.08% | 4545.45% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 21K | 0 | 0 | 0 | -7.48M | -11.47M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -4.25M | 0 | 0 | 42.81M | -175K | 0 | -9.61M | 0 | 0 | 7.48M | 11.47M |
| Cash from Financing | 126.62M | 53K | 0 | 0 | 120K | -602K | 273K | 56.7M | 18.2M | -356K | 300K | -10.12M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 126.62M | 53K | 0 | 0 | 120K | 17.23M | 273K | 56.7M | 18.2M | -356K | 300K | 124K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | -17.83M | 0 | 0 | 0 | 0 | 0 | -10.24M |
| Net Change in Cash | -11.25M | 6.34M | -913K | 4.95M | -6.57M | 5.78M | 11.14M | -4.5M | -512K | -7.98M | -9.13M | -22.39M |
| Free Cash Flow | -25.83M | -16.39M | -25.78M | -27.91M | -34.62M | -24.38M | -27.53M | -27.6M | -30.79M | -27.21M | -16.91M | -23.75M |
| FCF Margin % | - | - | - | - | -31.72% | -584.16% | -3480.15% | -3579.38% | -3600.82% | -10152.99% | -11428.38% | -23989.9% |
| FCF Growth % | 25.41% | 32.75% | 6.35% | -1.13% | -12.46% | 10.41% | -62.75% | -16.2% | 10.01% | 6.74% | 50.33% | 34.05% |
| FCF per Share | -0.30 | -0.19 | -0.30 | -0.32 | -0.40 | -0.31 | -0.32 | -0.34 | -0.49 | -0.45 | -0.28 | -0.40 |
| FCF Conversion (FCF/Net Income) | 1.17x | 0.84x | 0.74x | 0.85x | -0.45x | 0.67x | 0.91x | 0.88x | 1.08x | 0.67x | 0.42x | 0.58x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | -2K | 2K | -13K | 0 | 191K | 0 | 1.61M | 0 | 1.15M |